Phase IIB Trial of Neoadjuvant Oral Tamoxifen Versus Transdermal 4-hydroxytamoxifen in Women With DCIS of the Breast
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Afimoxifene (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Pharmacodynamics
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.
- 14 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.
- 19 Dec 2016 New trial record